RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 4,229,999 Value ($000) $17,301 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 1,348,684 Value ($000) $6,582 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 1,314,552 Value ($000) $6,652 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 2,655,711 Value ($000) $14,049 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 2,739,247 Value ($000) $18,517 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 234,223 Value ($000) $1,544 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 745,079 Value ($000) $5,588 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 340,374 Value ($000) $3,394 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 36,494 Value ($000) $360 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 303,090 Value ($000) $2,319 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 737,758 Value ($000) $5,511 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 605,515 Value ($000) $4,039 Avg Close $7.93 Range $6.40 - $9.73
Q4 2022
Shares 771,150 Value ($000) $5,946 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 501,870 Value ($000) $5,339 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 307,372 Value ($000) $2,502 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 909,970 Value ($000) $6,515 Avg Close $10.63 Range $5.80 - $18.23
Q4 2021
Shares 199,607 Value ($000) $3,420 Avg Close $18.82 Range $15.25 - $23.86